|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/574 |
| (11) | Patento numeris | 2997377 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14727633.1 |
| Europos patento paraiškos padavimo data | 2014-05-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-03-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-07-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/JP2014/063134 |
| Data | 2014-05-12 |
| (87) | Numeris | WO 2014/185540 |
| Data | 2014-11-20 |
| (30) | Numeris | Data | Šalis |
| 201361823034 P | 2013-05-14 | US |
| (72) |
FUNAHASHI, Yasuhiro, JP
KADOWAKI, Tadashi, JP
SACHDEV, Pallavi, US
|
| (73) |
Eisai R&D Management Co., Ltd.,
4-6-10 Koishikawa Bunkyo-ku, Tokyo 112-8088,
JP
|
| (54) | BIOMARKERS FOR PREDICTING AND ASSESSING RESPONSIVENESS OF ENDOMETRIAL CANCER SUBJECTS TO LENVATINIB COMPOUNDS |
| BIOMARKERS FOR PREDICTING AND ASSESSING RESPONSIVENESS OF ENDOMETRIAL CANCER SUBJECTS TO LENVATINIB COMPOUNDS |